Cancers emerge from many different paths. One path begins early, in embryonic development, when a protein complex called PRC2 ...

EpiciphAI公司正研发一款液体活检产品，通过检测无细胞染色质上的组蛋白标记，确定染色质片段的组织来源，并区分该组织中与疾病相关的状态。目前该公司仍处于种子前阶段，其技术的首个应用场景为难以进行活检的组织的癌症诊断与病情监测。

Researchers discovered that a small region of the PRC2 protein complex acts as a functional switch controlling gene silencing ...

In the intricate regulation of inflammation, metabolic reprogramming and posttranslational modification (PTM) have emerged as ...

One of the most widely accepted models for how cells remember their identity may be incorrect. This is shown in a new study ...

Researchers found a major histone modification linked to Polycomb proteins is not required for repressing developmental genes ...

Researchers at Karolinska Institutet have created the first detailed map showing how genetic activity is controlled in ...

Rising Prevalence of Cancer and Chronic Diseases, Demand for Personalized and Precision Medicine, and Integration with Multiomics and AI, Accelerate Demand for EpigeneticsNew York - NY, March 11, 2026 ...

New research shows epigenetic silencing may limit durability of AAV gene therapy in haemophilia by reducing long term ...

Cancer biology increasingly recognizes that cancer stem cells (CSCs) represent a critical subpopulation within tumors, marked by their self-renewal, ...

Researchers at Karolinska Institutet have created the first detailed map showing how genetic activity is controlled in ...

A new study led by researchers at Adelaide University and published in Science Advances has revealed why some cancers can grow and survive in the body, while others cannot. It turns out that intense ...